CON/217/RX4 = Supply of COBALT Drug Trial Requirements
What the buyer wrote
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust are seeking expressions of interest from capable bidders for the following opportunity: COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT) Introduction Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust (CNTW) and The University of Melbourne (UoM), Australia have successfully bid for funding to run 2 National, multi-site, placebo controlled clinical trial assessing if adjunctive Memantine use in patients with Lewy Body Dementia (LBD) and Parkinson’s Disease Dementia (PDD) has any effect on Clinical Global Impression (CGI) after 6 or 12 months. One trial will be based in the UK a…
Details
- What the buyer calls it
- CON/217/RX4 = Supply of COBALT Drug Trial Requirements
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Where
- in the North East
- Kind of work
- Pharmacy and medicines
Who the buyer named
Mr Gavin Thompson was the named contact on this notice.